CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$0.16
0.00 (-1.23%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +29,906.2% upside
Low Target $29.39
Average Target $48.34
High Target $58.89
Current Price $0.16
Current
$0.16
Target
$48.34
$29.39 $48.34 avg $58.89
Scenario Analysis
Bear Case
$29.39
18,143.3%
Low target
Base Case
$48.34
+29,906.2%
Avg target
Bull Case
$58.89
+36,454.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
Target vs 52W High
$48.34
+151.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%